– NORDIC GROUP B.V. A TRAVÉS DE SU FILIAL NORDIC PHARMA, INC. (EE.UU.), ANUNCIA LOS DETALLES DE LA PRESENTACIÓN DEL PÓSTER DEL GEL CANALICULAR LACRIFILL® EN SECO 2025 BERWYN, Pa., 1 de marzo de 2025 /PRNewswire/ — Nordic Pharma, Inc., una filial de Nordic Group B.V., anunció hoy una…
This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.